Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing.

Abstract excerpt

In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell-Free Nucleic Acids
• Share to Clonal Hematopoiesis